Eric S Zhou1, Peter E Manley2, Karen J Marcus2, Christopher J Recklitis3. 1. Dana-Farber Cancer Institute, David B. Quality of Life Clinic, Harvard Medical School, and eric_zhou@dfci.harvard.edu. 2. Dana-Farber Cancer Institute, David B. Quality of Life Clinic, Harvard Medical School, and Children's Hospital, Boston, MA. 3. Dana-Farber Cancer Institute, David B. Quality of Life Clinic, Harvard Medical School, and.
Abstract
OBJECTIVE: Children diagnosed with brain tumors are at risk for insomnia. We evaluated insomnia symptoms, medical and psychosocial correlates, and medical documentation of sleep-related issues in a neuro-oncology clinic. METHODS: 98 adult survivors of pediatric brain tumors provided data about sleep, psychological distress, and health-related quality of life. Medical records were reviewed for treatment-related information and for documentation of sleep-related issues. RESULTS: 26% of the sample reported insomnia symptoms as evidenced by poor sleep efficiency. Insomnia symptoms were associated with a migraine headache history, but not with other medical or psychosocial outcomes. Approximately one in three medical providers did not document discussing sleep during the survivorship visit. CONCLUSIONS: A sizeable number of pediatric brain tumor survivors experience insomnia symptoms. The survivorship visit is an ideal opportunity for providers to conduct a sleep evaluation for this at-risk population and to provide referrals for evidence-based insomnia treatment.
OBJECTIVE:Children diagnosed with brain tumors are at risk for insomnia. We evaluated insomnia symptoms, medical and psychosocial correlates, and medical documentation of sleep-related issues in a neuro-oncology clinic. METHODS: 98 adult survivors of pediatric brain tumors provided data about sleep, psychological distress, and health-related quality of life. Medical records were reviewed for treatment-related information and for documentation of sleep-related issues. RESULTS: 26% of the sample reported insomnia symptoms as evidenced by poor sleep efficiency. Insomnia symptoms were associated with a migraineheadache history, but not with other medical or psychosocial outcomes. Approximately one in three medical providers did not document discussing sleep during the survivorship visit. CONCLUSIONS: A sizeable number of pediatric brain tumor survivors experience insomnia symptoms. The survivorship visit is an ideal opportunity for providers to conduct a sleep evaluation for this at-risk population and to provide referrals for evidence-based insomnia treatment.
Authors: Eric S Zhou; Ann H Partridge; Karen L Syrjala; Alexis L Michaud; Christopher J Recklitis Journal: J Cancer Surviv Date: 2016-08-05 Impact factor: 4.442
Authors: Lisa M Jacola; Heather M Conklin; Matthew A Scoggins; Jason M Ashford; Thomas E Merchant; Belinda N Mandrell; Robert J Ogg; Elizabeth Curtis; Merrill S Wise; Daniel J Indelicato; Valerie M Crabtree Journal: J Pediatr Psychol Date: 2016-05-16